NASDAQ:PAVM - PAVmed Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $1.52 +0.05 (+3.40 %) (As of 07/20/2018 02:12 PM ET)Previous Close$1.56Today's Range$1.51 - $1.5952-Week Range$0.87 - $9.31Volume7,395 shsAverage Volume1.12 million shsMarket Capitalization$24.16 millionP/E Ratio-2.96Dividend YieldN/ABeta-2.41 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York. Receive PAVM News and Ratings via Email Sign-up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolNASDAQ:PAVM CUSIPN/A Webwww.pavmed.com Phone212-949-4319 Debt Debt-to-Equity Ratio-1.54 Current Ratio2.97 Quick Ratio2.97 Price-To-Earnings Trailing P/E Ratio-2.96 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book Value($0.22) per share Price / Book-6.91 Profitability EPS (Most Recent Fiscal Year)($0.52) Net Income$-9,510,000.00 Net MarginsN/A Return on EquityN/A Return on Assets-358.91% Miscellaneous Employees5 Outstanding Shares17,510,000Market Cap$24.16 PAVmed (NASDAQ:PAVM) Frequently Asked Questions What is PAVmed's stock symbol? PAVmed trades on the NASDAQ under the ticker symbol "PAVM." How were PAVmed's earnings last quarter? PAVmed Inc (NASDAQ:PAVM) issued its quarterly earnings results on Monday, May, 21st. The company reported ($0.21) EPS for the quarter. View PAVmed's Earnings History. When is PAVmed's next earnings date? PAVmed is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for PAVmed. What price target have analysts set for PAVM? 2 equities research analysts have issued twelve-month price objectives for PAVmed's stock. Their predictions range from $5.00 to $10.10. On average, they anticipate PAVmed's stock price to reach $7.55 in the next year. This suggests a possible upside of 396.7% from the stock's current price. View Analyst Ratings for PAVmed. What is the consensus analysts' recommendation for PAVmed? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PAVmed in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of PAVmed's key competitors? Some companies that are related to PAVmed include Sensus Healthcare (SRTS), Invuity (IVTY), Restoration Robotics (HAIR), Invo Bioscience (IVOB), Alphatec (ATEC), Arch Therapeutics (ARTH), Neovasc (NVCN), Spectral Medical (EDTXF), SANUWAVE Health, Inc. Common Stock (SNWV), CAS Medical Systems (CASM), iCAD (ICAD), Repro-Med Systems (REPR), Nephros (NEPH), CELLECT BIOTECH/S (APOP) and Valeritas (VLRX). Who are PAVmed's key executives? PAVmed's management team includes the folowing people: Dr. Lishan Aklog M.D., Chairman & CEO (Age 52)Mr. Dennis M. McGrath CPA, Exec. VP, CFO & Sec. (Age 61)Dr. Brian J. deGuzman M.D., Chief Medical Officer (Age 53) Has PAVmed been receiving favorable news coverage? Media coverage about PAVM stock has been trending somewhat positive this week, Accern Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PAVmed earned a daily sentiment score of 0.10 on Accern's scale. They also assigned media stories about the company an impact score of 44.60 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. How do I buy shares of PAVmed? Shares of PAVM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is PAVmed's stock price today? One share of PAVM stock can currently be purchased for approximately $1.52. How big of a company is PAVmed? PAVmed has a market capitalization of $24.16 million. The company earns $-9,510,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis. PAVmed employs 5 workers across the globe. How can I contact PAVmed? PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The company can be reached via phone at 212-949-4319 or via email at [email protected] MarketBeat Community Rating for PAVmed (NASDAQ PAVM)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 74 (Vote Outperform)Underperform Votes: 91 (Vote Underperform)Total Votes: 165MarketBeat's community ratings are surveys of what our community members think about PAVmed and other stocks. Vote "Outperform" if you believe PAVM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAVM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/20/2018 by MarketBeat.com StaffFeatured Article: What do I need to know about analyst ratings?